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Pasteurella multocida toxin (PMT) activates the G-proteins Gai (1-3), Gaq, Ga11, Ga12 and Ga13 by deami-
dation of speciﬁc glutamine residues. A number of these alpha subunits have signalling roles in neurones.
Hence we studied the action of this toxin on rat superior cervical ganglion (SCG) neurones and NG108-15
neuronal cells. Both Gaq and Ga11 could be identiﬁed in SCGs with immunocytochemistry. PMT had no
direct action on Kv7 or Cav2 channels in SCGs. However PMT treatment enhanced muscarinic receptor
mediated inhibition of M-current (Kv7.2 þ 7. 3) as measured by a 19-fold leftward shift in the
oxotremorine-M concentrationeinhibition curve. Agonists of other receptors, such as bradykinin or
angiotensin, that inhibit M-current did not produce this effect. However the amount of PIP2 hydrolysis
could be enhanced by PMT for all three agonists. In a transduction system in SCGs that is unlikely to be
affected by PMT, Go mediated inhibition of calcium current, PMT was ineffective whereas the response
was blocked by pertussis toxin as expected.
M1 muscarinic receptor evoked calcium mobilisation in transformed NG108-15 cells was enhanced
by PMT. The calcium rises evoked by uridine triphosphate acting on endogenous P2Y2 receptors in
NG108-15 cells were enhanced by PMT. The time and concentration dependence of the PMT effect was
different for the resting calcium compared to the calcium rise produced by activation of P2Y2 receptors.
PMT’s action on these neuronal cells would suggest that if it got into the brain, symptoms of a hyper-
excitable nature would be seen, such as seizures.
 2013 The Authors. Published by Elsevier Ltd. Open access under CC BY license.1. Introduction
Pasteurella multocida infections in humans are rare and if they
occur it is usually due to contamination from a domestic animal.
However there have been a number of reports of P. multocida
meningitis (Green et al., 2002; O’Neill et al., 2005; Kawashima et al.,
2010; Guet-Revillet et al., 2013) in which neurological complica-
tions are seen in between 17 and 43% of cases, most of which are
seizures (Nakwan et al., 2009; Guet-Revillet et al., 2013). Of further
concern is the possible link between the P. multocida infection and
cancer (Lax, 2012).
The main virulent agent of P. multocida is a 146 kDa, 1285 amino
acid, protein called P. multocida toxin (PMT). Not all P. multocidatroenterology, Barts and the
Mary University of London,
r Ltd. Open access under CC BY licenseisolates are toxigenic, although very few human isolates of
P. multocida have been tested for toxigenicity (Holst et al., 1992;
Donnio et al., 1991). The toxigenic status of the isolates linked
with neurological infections is not known. To date PMTactions have
been investigated using a range of non-neuronal cells such as Swiss
3T3 (Staddon et al., 1991; Babb et al., 2012), HEK 293 (Repella et al.,
2011), COS-7 (Waldron et al., 2012), CHO (Bünemann et al., 2000)
and murine embryonic ﬁbroblast (Orth et al., 2009) cell lines.
However there is very limited knowledge on the effects of this toxin
on neurones or neuronal cells, with the exception of the work of
Brothers et al. (2011) on membrane interactions of PMT in mouse
neuroblastoma rat glioma hybrid (NG108-15) cells. Here we have
investigated the cellular effect of PMT on primary neurones in
culture (rat superior cervical sympathetic ganglion (SCG) cells) and
a differentiated neuronal cell line (NG108-15).
PMT is a monomeric protein which has been sequenced, its
functional domains analysed and a crystal structure obtained. The
N-terminal region contains the binding and translocation domain
that leads to its endocytosis (Baldwin et al., 2004; Pullinger et al.,
2001). The C-terminal region contains the catalytic site and
amino acid residues C1165, H1205 and H1223 are essential for its.
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2003; Kitadokoro et al., 2007). The crystal structure suggests that
the protein has three subdomains C1, C2 and C3. C1 (the most N-
terminal region) has similarity with Clostridium difﬁcile toxin B, and,
consistent with the above, seems to be involved in membrane
targeting. The other subdomains contain the catalytic and molec-
ular recognition sites (Kitadokoro et al., 2007).
PMT is a mitogen for ﬁbroblasts and activates a range of intra-
cellular signalling pathways including PLC-b-mediated phosphoi-
nositide turnover (Staddon et al., 1991;Wilson et al., 1997: Seo et al.,
2000), Rho (Blocker et al., 2006) and mTORC1 (Oubrahim et al.,
2013a, 2013b). Like pertussis and cholera toxins, PMT’s molecular
target are G-protein alpha subunits, in particular Gaq, Ga12, Ga13,
Gai (1e3) and Ga11 (Orth and Aktories, 2010; Orth et al., 2013).
Unlike pertussis and cholera toxins the action of PMT on the G-
protein alpha subunit is not ADP-ribosylation but deamidation of a
glutamine residue (Orth et al., 2009, 2013; Babb et al., 2012). Here,
in both SGC neurones and NG108-15 cells we have studied a
number of signal transduction pathways to investigate the likely
action(s) of the PMT on neurones.
2. Materials and methods
2.1. SCG cell culture
SpragueeDawley rats (P17) were asphyxiated with rising CO2 and decapitated.
The superior cervical sympathetic ganglia (SCG) were removed and placed in
collagenase (500 U ml1, Sigma, Poole, UK) for 15 min followed by trypsin
(1 mg ml1, Sigma) for 30 min. Ganglia were triturated with ﬁre-polished glass
pipettes, spun down, resuspended and plated onto either laminin (Sigma)-coated
coverslips or 35 mm plastic dishes. Cultures were kept for up to 7 days at 37 C (5%
CO2) in L-15 medium supplemented with 10% foetal bovine serum, 2 mM glutamine,
24 mM NaHCO3, 38 mM glucose, 50 U ml1 penicillin-streptomycin and 25 ng ml1
nerve growth factor (Tocris, Avonmouth, UK). Unless otherwise indicated the ma-
terials were from Invitrogen (Paisley, UK).
2.2. NG108-15 cell culture
M1 muscarinic acetylcholine receptor transformed NG108-15 cells were
cultured as described previously (Robbins et al., 1993; Bowden et al., 1999). Brieﬂy
cells were cultured in DMEM (supplemented with 5% FCS, HAT, penicillin & strep-
tomycin), differentiated with PGE1 (10 mM) and IBMX (50 mM) and maintained in an
incubator at 37 C and 10% CO2.
2.3. Immunocytochemistry
SCG cells were plated onto coverslips and preincubated with 500 ng ml1 PMT
or vehicle for 24 h at 37 C. The cells were washed in phosphate buffered saline (PBS,
3  5 min) and ﬁxed in 4% paraformaldehyde in 0.1 M phosphate buffer for 30 min.
The reaction was then quenched with 0.37% glycine and 0.27% ammonium chloride
in PBS for 2  10 min, the cells were washed in PBS (3  5 min) and permeabilised
with 0.1% Triton-X in PBS for 15 min. The blocking step was carried out with 2%
bovine serum albumin (BSA) and 2% foetal calf serum in PBS for 60 min, following
which the cells were washed in 1 mg ml1 BSA in PBS (PBSBSA, 3  5 min) and
exposed to the primary antibodies overnight at 4 C. Four control and 4 PMT treated
coverslips were exposed to an N-terminal antiGaq antibody (rabbit anti mouse/rat/
human, Santa Cruz Biotechnology Inc, Santa Cruz, CA) at a dilution of 1:200 in
PBSBSA. Similarly 4 control and 4 treated coverslips were exposed to an antiGa11
antibody (rabbit anti mouse/rat/human, Santa Cruz) at the same dilution. After
washing in PBSBSA (6 5min) cells were exposed to a secondary donkey anti rabbit
antibody (Alexa 488 FITC, Invitrogen) at a dilution of 1:1000 in PBSBSA for 60 min at
room temperature. Cells were then washed in PBSBSA (5  3 min), PBS (3  5 min)
and deionised water (3  5 min). The coverslips were then mounted with ﬂuores-
cent mounting medium (DAKO) on glass slides (VWR International, Poole, UK) and
sealed with nail varnish (Rimmel, London, UK). Fluorescence was observed on the
microscope/camera system detailed above with the excitation wavelength set at
480 nm, zero pixel binning and 40 objective.
2.4. Electrophysiology
For potassium current recording, SCG cells that had been plated on 35 mm Petri
dishes were superfused at room temperature (21e23 C) with a solution containing
(mM): NaCl (144), KCl (2.5), MgCl2 (0.5), CaCl2 (2), HEPES (5), glucose (10), tetrodo-
toxin (0.0005), pH7.4with Tris base, and291mOsM. Patch electrodeswere fabricatedfrom thinwalled borosilicate glass (Harvard, Edenbridge, UK) on a 2 stage puller (PC-
10; Narishigie, London, UK) polished to 1.5e3.0 MU (Narishigie NF-9). Electrodes
were ﬁlled with a solution containing (mM): K acetate (80), KCl (30), HEPES (40),
MgCl2 (3) EGTA (3), CalCl2 (1), pH 7.2 with NaOH (16), 270 mOsM. Cell membranes
were permeabilised with freshly-made ampotericin B (1 mg 20 ml1 DMSO, Sigma)
and added to the pipette solution at 2 ml ml1. After the series resistance had reduced
to at least 15MU (typically 6e12MU) currentswere recordedwith anAxopatch 200A
ampliﬁer (Axon Instruments, Foster City, CA) and displayed on a PC running PClamp8
via a preampliﬁer (Cyberamp 320, Axon Instruments) and an analogue-to-digital
converter (Digidata 1200, Axon Instruments). Currents were ﬁltered at 0.6 KHz and
sampled at 10 KHz. Junction potentials measured at the end of the recordings were
around 1 mV and were small enough not to be corrected for. For calcium channel
current recordings the cells were plated onto dishes coated with poly-L-lysine to
reduce the speed of neurite outgrowth and thereby improve the cells’ spatial elec-
trical characteristics. The CaCl2 in the superfusatewas replaced by BaCl2 (10mM) and
the pipette solution consisted of (mM): CsCl (110), HEPES (40), MgCl2 (3), BAPTA (20),
tetrodotoxin (0.0005), pH 7.3 with CsOH, 269 mOsM. BAPTA (20 mM) was used to
suppress voltage-independent (non-Go-mediated) inhibition (Beech et al., 1991).
Calcium channel currents were recorded in whole cell mode using a dual pulse
protocol in which cells were clamped at 70 mV then depolarised twice to 0 mV for
100 ms each with an intervening strong depolarisation to þ90 mV for 50 ms to
evaluate voltage-dependence of the inhibition (Hille, 1994).
2.5. GFP-PLCd-PH imaging
Intranuclear injections of SCG cells with the cDNA plasmid for the pleckstrin
homology domain of phospholipase C-d1 in an eGFP-C1 vector (GFP-PLCd-PH, kindly
provided by T. Meyer, Stanford University, USA; see Stauffer et al., 1998) were per-
formed one day after culturing. The GFP-PLCd-PH plasmid (100 mg ml1) was dis-
solved in a solution containing (mM) NaCl (154) HEPES (5) KCl (2.5) MgCl2 (0.5), pH
7.4 (1 M, NaOH) and ﬁltered (0.2 mm) by centrifugation at 13,000 rpm. Cells were
impaled with 50 MU electrodes using an automated micro-injector (Transjector
5246, Eppendorf, Hamburg, Germany) and after injections were returned to the
incubator for 24 h. Fluorescence recordings were performed on an inverted mi-
croscope as used for the calcium imaging. Cells were excited at 475 nm with a
monochromator (TILL-optoelektronics); emission wavelength was 530 nm. The
images were acquired by a 12-bit digital camera (C4880/80, Hamamatsu) and pro-
cessed using a FITC pseudo-colour palette applied to the grey-scale images. Images
were taken at around one per second with exposure times of 300e800 ms. Digital
deconvolution (0.5 mm steps) was performed on-line with a nearest neighbour al-
gorithm using Openlab software (Improvision).
2.6. Intracellular calcium measurement
SCG and NG108-15 cells on glass coverslips were incubated in the dark with
Indo-1 AM (5 mM, 1 h, 37 C), placed on a stage of a ﬂuorescent microscope and
superfused with a buffer solution containing (mM): NaCl 120.0, KCl 3.0, MgCl2 1.2,
NaHCO3 22.6, glucose 11.1, HEPES 5.0, CaCl2 2.5, CdCl2 0.1, pH 7.4. UTP, UDP or
oxotremorine-M was applied via the superfusate at room temperature. Bright cells
were chosen under the microscope and UTP, UDP or oxotremorine-M was each
applied for 5 s in order to generate a non-cumulative concentration response curves.
Receptor agonists were applied in the presence of CdCl2 (100 mM) to prevent acti-
vation of voltage gated calcium channels. By using a photometric dual emission
system, ﬂuorescence was determined from single cells loaded with the dye Indo-1
(Grynkiewicz et al., 1985). Initially, an area of the coverslip with no cells present
was used to offset background light levels and this was routinely checked and
adjusted between cells and dishes. To carry out the measurements of Indo-1, the
excitation light was passed through a neutral-density ﬁlter and a dichotic mirror,
emitted light was passed through a 510 nm barrier ﬁlter. [Ca2þ]i was assessed by
measuring the 405/488 nm emission ratio, which was then viewed on a personal
computer running pClamp6 software. Ratiometric measurements (R) were con-
verted to intracellular calcium concentrations ([Ca2þ]i) using the equation:
[Ca]i ¼ b*Kd*(R  Rmin)/(Rmax  R). Where b*Kd ¼ 722 nM, Rmax ¼ 3.94 and
Rmin ¼ 0.28. See Hayat et al. (2003) for details.
2.7. Data analysis
M-current deactivation relaxations were ﬁt with a biexponential function
(f(t) ¼PAi et/si þ C) extrapolated to the beginning of the voltage step and the sum
of the amplitudes of each component taken. Activation curves were individually
ﬁtted by the expression y ¼ A1 e A2/(1 þ e(x-x0)s) þ A2 where x0 ¼ half maximal
conductance and s ¼ slope. Parameters are given as mean  SEM. Concentration
inhibition curves were constructed by ﬁtting the data from each cell to a Hill
function (y ¼ Vmax*(xn/IC50n þ xn)) and averaging the parameters log IC50, n (¼ slope)
and Vmax (usually set at 100%). GFP-PLCd-PH measurements were obtained from a
region of interest within the cytosol of the cell, avoiding the nucleus, and expressed
as a percent of background subtracted basal ﬂuorescence. Statistical tests used were
two-tailed t-tests (paired or unpaired as appropriate) or ANOVAs with post hoc tests
as stated.
Fig. 1. Immunostaining of rat SCG cells with antibodies to rat Gaq and Ga11. A:
representative immunostaining of control cells for antibodies directed against Gaq or
Ga11. These images were taken at the same camera exposure of 1.0 s to compare
ﬂuorescent staining of the two G-protein subtypes. B: comparative immunostaining for
Gaq (upper row) and Ga11 (lower row) in control and PMT (500 ng ml1, 18e24 h) pre-
treated cells. Exposure times were 0.6 s and 2 s for Gaq and Ga11 respectively. The
scale bar (25 mm) applies to all panels.
Fig. 2. Preincubation with PMT or CTX has no effect on M-current activation curves. A)
Example of a currentevoltage relationship. Sympathetic SCG neurons were held
at 20 mV to activate the Kv7/M-current then stepped negative every 30 s for
1 s in 10 mV increments to deactivate the current. Current traces show the time-
dependent current decline as M-channels close. B) Activation curves measured from
the current deactivations (see Methods) for control cells (open squares), cells pre-
incubated in CTX (500 ng ml1) for 18e24 h (open circles) or in PMT (500 ng ml1) for
18e24 h (ﬁlled circles). Solid lines are Boltzmann ﬁts to the mean data (see Methods
and Materials); parameters of the curves are given in Results.
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Pertussis toxin, PMT, BAPTA-AM and Indo-1-AM were obtained from Calbio-
chem (Nottingham, UK). Wild type and the non mitogenic/non toxigenic C1165S
mutant PMT was prepared as previously described (Ward et al., 1998). Cholera toxin,
norepinephrine, oxotremorine M, angiotensin II, bradykinin, UTP and UDP were
from Sigma and TTX from Tocris.
3. Results
3.1. PMT does not drastically alter Gq or G11 expression in SCG
Using antibodies directed against rat Gaq or rat Ga11 we found
both ﬂuorescence for Gaq and Ga11 antibody labelling in control
cells (Fig.1A; n¼ four coverslips of each). This accordswith previous
mRNA measurements (Caulﬁeld et al., 1994). When we compared
the levels of ﬂuorescence in control or PMT pre-treated cells we
could see no striking differences in either the amount or distribution
of the immunolabelling for either Ga11 or Gaq (Fig. 1 B).
3.2. PMT does not modify M-current amplitude or kinetics
Acute application (1e10 min) of PMT (100 ng ml1) to sym-
pathetic (SCG) neurons had no effect on the amplitude of the M-current (inhibition þ1.2  0.5%, n ¼ 4). This is not surprising
since the toxin acts intracellularly and takes a few hours
to internalise (Lax et al., 2004). All of the following experiments
were performed on cells that had been preincubated in
the toxin (500 ng ml1) for 18e24 h at 37 C unless otherwise
stated.
We compared the effect of preincubating SCG cells for 18e
24 h in PMT (500 ng ml1), or in cholera toxin (500 ng ml1, as a
negative control: Guo and Schoﬁeld, 2003), with control cells. The
deactivation relaxation amplitudes of the M current (Fig. 2 A),
measured at 50 mV, were not signiﬁcantly different (ANOVA)
between controls (201  20 pA, n ¼ 19), cells incubated in cholera
toxin (202  19 pA, n ¼ 8) and cells preincubated in PMT
(166  16 pA, n ¼ 18). Similarly, activation curves (Fig. 2B) were not
different (one way ANOVA) after these treatments in terms of their
half activation potentials (46.6  2.4 mV, 50.7  2.1 mV
and 47.0  2.2 mV in 12 controls, 9 CTX treated and 11 PMT
treated cells respectively) or slope values (8.70  0.55, 8.83  0.21
and 9.08  0.58 mV e-fold1). Maximum cellular conductances
were 10.2  1.3, 19.8  2.9 and 12.8  1.5 nS respectively. Thus, SCG
neuron M-current is not directly affected by PMT or CTX.
Fig. 3. Preincubation with PMT increases the sensitivity of the M-current to inhibition
by oxotremorine-M. A(i) example of a PMT-treated cell’s response to oxotremorine-M.
Records show current relaxations evoked by holding the cell at 20 mV and then
stepping to 50 mV for 1 s. Trace cont: control; trace oxo-M: in the presence of 0.1 mM
oxotremorine-M; trace wash: after washing in drug free solution. A(ii): time-course of
the changes in deactivation current amplitudes illustrated in A(i). Measurements were
made every 30 s. Oxotremorine-M application is shown by the solid bar beneath the
points. B) Mean (SEM) concentrationeinhibition curves in control cells (open circles),
CTX treated cells (ﬁlled circles) and PMT treated cells (ﬁlled squares). Curves show
least-squares Hill ﬁts (solid lines) with the numerical data given in Table 1.
Table 1
Effects of PMT on the oxotremorine-M concentration-M(Kv7) current inhibition
curves.
Toxin Source Preincubation
time (hours)
IC50 (mM) Slope N
Control e e 1.32 (0.65e2.67) 0.75  0.16 6
CTX Sigma 18e24 1.39 (0.55e3.54) 0.50  0.05 7
PMT Calbiochem 18e24 0.07 (0.02e0.22) 0.90  0.15 9
PMT Calbiochem 4e6 0.76 (0.13e4.29) 0.75  0.16 6
PMT Lax 18e24 0.09 (0.05e0.16) 1.25  0.18 6
The data from each cell was ﬁtted to a Hill equation (see Materials and Methods).
The IC50s are given as the geometric mean with 95% conﬁdence limits in brackets
and slope values are given as the mean  SEM. Maximal inhibition was constrained
to 100% and N is the number of cells tested.
Fig. 4. PMT alters M-current sensitivity to muscarinic receptor but not angiotensin or
bradykinin receptor mediated inhibition. Comparison of the effect of 1 nM bradykinin
(ﬁlled bars) and 100 nM oxotremorine-M (open bars) on M-current amplitude in
control (A(i): open symbols) and PMT-pretreated (A(ii): ﬁlled symbols) SCG neurons.
Note that the inhibition by oxotremorine-M is enhanced whereas inhibition by bra-
dykinin was unaffected by PMT. M-currents were measured every 30 s as deactivation
tail amplitudes using a voltage command to 50 mV from a holding potential
of 20 mV for 1 s. B: % inhibition of M-current induced by angiotensin II (ATII, 10 and
100 nM) and bradykinin (BK, 1 nM) in control (light bars) and PMT pre-treated cells
(dark bars). Numbers of cells in each group are indicated in brackets.
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mediated inhibition
M-currents in rat SCG neurons are inhibited by muscarinic
acetylcholine-receptor (mAChR) agonists such as oxotremorine-M
(Oxo-M) acting on M1-mAChRs coupled mainly to Gq (Haley
et al., 1998). Preincubation of cells in PMT (500 ng ml1, Calbio-
chem) for 18e24 h shifted the Oxo-M concentrationeinhibition
curve 19-fold to the left compared with control and CTX-treated
cells (Fig. 3 and Table 1). Very little, if any effect (1.7-fold shift)
was seen with shorter incubation periods of 4e6 h (Table 1).
3.4. PMT does not alter angiotensin II or bradykinin-mediated
inhibition of the M-current
Both angiotensin (Constanti and Brown, 1981; Shapiro et al.,
1994) and bradykinin (Jones et al., 1995) inhibit M-current in rat
SGC neurons. In control cells, application of 1 nM bradykinin pro-
duced around 40% inhibition of the M-current and 100 nM oxo-
tremorine had no effect (Fig. 4A). A cell pretreated with PMT
(500 ng ml1, 18e24 h) showed a similar response to bradykininbut an enhanced response to oxotremorine-M. Pooled data
conﬁrmed that the inhibition produced by 1 nM bradykinin in PMT
treated cells (43.2  6.3%) was not signiﬁcantly different from that
(37.6  4.1%) in control cells (n ¼ 5 for both). The inhibition pro-
duced by either 10 or 100 nM angiotensin II was also not altered
signiﬁcantly by PMT pre-treatment (Fig. 4B).
Fig. 5. Effects of PMT on GFP-PLCd-PH translocation. (A). Example of the membrane-
to-cytosolic translocation of the GFP-PLCd-PH construct (measured as increase in
cytosolic ﬂuorescence over basal ﬂuorescence (F/F0) in a deﬁned region of interest) in a
control cell in response to 0.1 mM and 10 mM oxotremorine-M (open and light ﬁlled bar
respectively) and to 1 nM bradykinin II (dark ﬁlled bar). Note: inset shows expanded
trace of oxotremorine-M (0.1 mM) application. (B). Similar experiment to (A) but in a
PMT (500 ng ml1, 18e24 h) pre-treated SGC neuron. Drug applications and inset as in
(A). (C). Pooled data showing % increase (mean  SEM) over basal cytosolic ﬂuores-
cence for two concentration of oxotremorine-M (0.1 and 10 mM), 0.1 mM angiotensin II
and 1 nM (0.001 mM) bradykinin. Open bars: control cells; ﬁlled bars: PMT pre-treated
cells. Numbers in brackets indicate number of cells tested and * indicates signiﬁcant
change (P < 0.05).
Fig. 6. PMT does not alter Go mediated calcium channel current inhibition. (A).
Example traces of calcium currents evoked by a twin-pulse protocol (c). Cells were
voltage clamped at 70 mV and stepped to 0 mV for 100 ms before (P1) and after (P2)
a 50 ms command pulse to þ90 mV. In a control cell inhibition produced by norepi-
nephrine (n, 10 mM) shows a strong block during P1 which is very much reduced after
the þ90 mV depolarising pulse at P2. The pooled data (B) shows that there was no
difference in the inhibition between the control cells (ﬁlled bars) and those pretreated
with PMT (500 ng ml118e14 h; shaded bars). On the other hand cells pretreated with
Pertussis toxin (PTX, 500 ng ml1, 18e24 h) showed almost complete abolition of the
response, suggesting that the inhibition recorded under these conditions (whole cell
and high calcium buffering) was mostly mediated by Go activation. The number of cells
tested for each condition is given in brackets.
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It has been suggested that an important mechanism for mAChR-
mediated inhibition of M-current is the depletion of membrane
phosphatidylinositol-4, 5-bisphosphate (PIP2) due to Gq-activated
phosphoinositide turnover (Suh and Hille, 2002; Zhang et al.,
2003; Suh et al., 2004; Winks et al., 2005; Robbins et al., 2006).
Therefore we used the membrane-to-cytosol translocation of the
ﬂuorescent marker, GFP-PLCd-PH as an index of phosphoinositide
turnover (Stauffer et al., 1998; Varnai and Balla, 1998; Nahorski
et al., 2003), to test if the enhanced sensitivity to muscarinic re-
ceptor stimulation could be detected upstream from channel
closure. In control cells a sub-threshold concentration of
oxotremorine-M (100 nM) did not produce any translocation of the
probe (0.9  0.7%, n ¼ 12). However, in PMT treated cells there wasa signiﬁcant increase (P < 0.01) in translocation (12.9  4.0%,
n ¼ 16; Fig. 5). At a maximal concentration of oxotremorine-M
(10 mM) there was no difference in the translocation (control cells
70.19.6%, n¼ 12; PMT-treated cells 68.9 6.5%, n¼ 15). Similarly
a submaximal (1 nM) concentration of bradykinin produced no
signiﬁcant translocation in control cells (0.6  0.9%, n ¼ 4) but a
signiﬁcant (32.5  10.7%, n ¼ 5; P < 0.05) translocation in PMT
treated cells. Likewise, angiotensin (100 nM) caused no trans-
location in control cells (0.4  0.8%, n ¼ 4) but a signiﬁcant
(25.6 6.8%, n¼ 5; P< 0.05) translocation in cells treatedwith PMT
(see Fig. 5).
Fig. 7. M1 muscarinic receptor mediated [Ca]i increases in transformed NG108-15 cells
are enhanced by PMT. Concentration response curves for oxotemorine-M evoked cal-
cium increases in NG108-15 cells. Control cell (open circles, N ¼ 10), PMT (500 ng ml1,
18e24 h) pre-treated cells (ﬁlled circles, N ¼ 6) and PMT C1165S (500 ng ml1, 18e
24 h) pre-treated cells (open triangles, N ¼ 5). The points where ﬁt with Hill curves as
described in text.
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In order to test the action of PMTon a transduction pathway that
does not involve Gi, Gq/G11 or G11/G12 we recorded calcium cur-
rents under conditions where the Go mediated, fast, voltage and
pertussis toxin sensitive inhibition predominated. SCG neurons
were patched in whole cell mode with 20 mM BAPTA added to the
internal solution (Beech et al., 1991). Norepinephrine (10 mM) was
used to inhibit the calcium current (Fig. 6A); under these conditions
this inhibition (via a2-adrenoceptors) is solely mediated by Go
(Caulﬁeld et al., 1994; Haley et al., 1998; Delmas et al., 1998). SuchFig. 8. UTP concentration response curves showing responses in PMT treated cells comp
concentration response curves of control (open circles) and 500 ng ml1 (128-24 h) PMT
P < 0.05 (t-test).inhibition is voltage-dependent, and is reduced by strong depo-
larisation (see Hille, 1994). Thus, as shown in Fig. 6B, inhibitionwas
48.3  6.5% for the ﬁrst pulse to 0 mV (P1) but was reduced to
25.2  5.9% for the second pulse (P2) applied after an intervening
step toþ90 mV (n ¼ 9). PMT pre-treatment (500 ng ml1, 18e24 h)
had no signiﬁcant effect on either the degree of inhibition observed
during the ﬁrst pulse or the extent to which the inhibition was
relieved by the depolarising step (P1 inhibition 49.2  6.8%. P2
inhibition 29.9  5.8%; n ¼ 8). In contrast, in cells pretreated with
Pertussis toxin PTX (500 ng ml1, 18e24 h), inhibition was essen-
tially abolished (P1 inhibition 6.0  3.1%; P2 inhibition 3.5  0.9%;
n ¼ 4).
3.7. Rat SCGs do not show calcium increases
Resting [Ca]i in control SCGs was 77.7  4.4 nM, (n ¼ 46) and in
PMT (500 ng ml1, 18e24 h) treated cells it was not signiﬁcantly
different at 69.1  6.4 nM (n ¼ 19). Furthermore a signiﬁcant cal-
cium rise could not be detected following applications of
oxotremorine-M (10 mM; see also (Cruzblanca et al., 1998; Delmas
et al., 2002)), bradykinin (100 nM) or angiotensin II (100 nM)
(0.6  0.6 nM, (n ¼ 5), 2.8  6.1 nM (n ¼ 11) and 1.3  0.9 nM
(n ¼ 3) respectively). There was no change in the effect of these
compounds after PMT pretreatment (500 ng ml1, 18e24 h).
Therefore we used NG108-15 cells in which we had already shown
a robust calcium rise mediated by a range of receptors includingM1
muscarinic (Robbins et al., 1993; Bowden et al., 1999) and P2Y2
purinergic (Chueh et al., 1993; Matsuoka et al., 1995; Czubayko and
Reiser, 1996; Watano et al., 2002).
3.8. PMT ampliﬁes M1 mAChR mediated calcium signals in NG108-
15 cells
As shown in Fig. 7 oxo-M concentration response curves
were generated in control cells and cells incubated in PMT
(500 ng ml1) for 18e24 h. In control cells the oxo-M EC50 wasared to control cells. A) Example traces where bars indicate UTP application and B)
treated (ﬁlled squares) NG108-15 cells. N ¼ 5 for both groups of cells and * indicates
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(n ¼ 10). Cells exposed to PMT had a similar EC50 of 3.2  0.3 mM
but a signiﬁcantly (P < 0.05, ANOVA) increased maximal
response of 674  167 nM (n ¼ 6).
3.9. PMT increases resting [Ca]i and ampliﬁes calcium signals
mediated by P2Y2 receptor activation in NG108-15 cells
NG108-15 cells express two purinergic receptors which can
couple to phosphoinostide turnover, namely P2Y6 and P2Y2 (Sak
et al., 2001). Under our conditions we found no responses to UDP
(100 mM, n ¼ 3) and consistent calcium signals to UTP (100 mM,
n ¼ 45) indicating that the response was mainly mediated by P2Y2
receptors that are insensitive to UDP. Furthermore the UTP calcium
responses were not dependent on [Ca]o or the action of voltage-
gated calcium channels as calcium responses to UTP were
368  71 nM in 2.5 mM [Ca]o, 363  122 nM in 0 mM [Ca]o and
365  101 nM in CdCl2 (100 mM), n ¼ 5 for each condition. These
data suggest the response was predominantly mediated by calcium
mobilisation from intracellular stores.
Similar to M1 mACh receptor calcium mobilisation in NG108-15
cells (Fig. 7), PMT (500 ng ml1 for 18e24 h) enhanced P2Y2 cal-
cium responses evoked by UTP (Fig. 8). This effect was studied in
more detail in Fig. 9 where both the concentration- and time-
dependence of PMT was measured on the resting [Ca]i, EC50 and
maximal response of the UTP evoked calcium signals.
Of the three parameters measured the UTP EC50 was the most
sensitive as a signiﬁcant increase (P < 0.05, ANOVA, Dunnett post
hoc test) was seen at 10 ng ml1. Signiﬁcant changes in resting [Ca]i
was next seen (100 ng ml1) followed by maximal UTP response at
the maximal concentration of 500 ng ml1 (Fig. 9B). In terms of
speed of response the resting [Ca]i was the earliest event, within 3e
4 h a signiﬁcant increase was seen this was followed by an increase
in UTP calcium response maximum at 12e24 h and a complete loss
of response by 42e48 h (Fig. 9B).Fig. 9. Concentration and time dependence of PMT on UTP induced calcium responses in N
(ﬁlled circles), maximal UTP evoked calcium response (ﬁlled squares) and UTP EC50 (ﬁlled t
vertical axis of A indicate control values, in the absence of PMT. The time dependence was do
controls in A and time zero in B.3.10. Mutant PMT
To investigate whether it is the activation of Gaq or the phos-
phorylation of Gaq that is important for these effects we have used
a mutant form of PMT, C1165S, which has lost its toxicity and
mitogenicity but which does not appear to affect the endogenous
phosphorylation of Gaq (Baldwin et al., 2003). SCG cells pre-
incubated with 500 ng ml1 PMT (C1165S) were compared with
cells preincubated with wild-type toxin from the same source. As
before, wild-type PMT (Lax) produced a 15-fold leftward shift in the
oxotremorine-M concentration (M)Kv7 current inhibition curve,
mean IC50 (95% conﬁdence limits) 0.09 (0.05e0.16) mM without
signiﬁcantly altering the slope, mean (SEM): 1.25  0.18, (n ¼ 6).
The C1165S mutant PMT (500 ng ml1 for 18e24 h) produced no
effect on the oxotremorine-M concentration (M)Kv-7 inhibition
curve IC50 0.30 (0.14e0.67) mM, slope 0.84  0.16, (n ¼ 6). Similarly
the enhancement of the muscarinic receptor mediated calcium
response in NG108-15 cells was not seen with the C1165S mutant
PMT (Fig. 7). The cells exposed to PMT C1165S were not signiﬁ-
cantly different from control with the EC50 of 3.1  0.2 mM and
maximal response of 223  62 nM (n ¼ 5), suggesting that this
mutant is inactive.
4. Discussion
4.1. Neuronal actions
To date studies on the nervous system or neuronal cells with
PMT have been very limited. It has been demonstrated that PMT
interacts with NG108-15 cell membranes by binding to phospho-
lipids rather than gangliosides (Brothers et al., 2011). We have
substantially added to this knowledge by showing that PMT can
(whereas cholera toxin cannot) enhance the muscarinic receptor
inhibition of Kv7.2 þ 7.3 (M) current in rat SCG cells. However this
effect is restricted to only some receptors that are known toG108-15 cells. A) PMT concentration- and B) time-dependent changes in resting [Ca]i
riangles). The concentration dependence was done at 18e24 h and the symbols on the
ne at 500 ng ml1. N ¼ 5 for all points and * indicates P < 0.05 by ANOVA, compared to
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when we look at the upstream hydrolysis of PIP2 (Fig. 5). Here
muscarinic ACh, angiotensin II and bradykinin receptor mediated
responses are enhanced by PMT. This may highlight a difference in
the regulation of Kv7.2þ 7.3 channels by these receptors (see later).
PMT has no effect on the adrenoceptor mediated inhibition of
voltage gated calcium currents, which are blocked by pertussis
toxin (Fig. 6). In NG108-15 cells transfected with the gene for M1
muscarinic receptors the calcium mobilisation was enhanced as it
was for endogenous purinergic P2Y2 receptors (Figs. 7 and 8). PMT
is a potent toxin, with which we noted effects from 10 ng ml1. The
earliest effect of PMT was seen at 3e4 h, which was an increase in
resting [Ca]i followed by a dramatic increase in maximal response
to UTP at 12e24 h, by 42e48 the response was abolished
completely (Fig. 9). The time delay for the effect of PMT on calcium
mobilisation is consistent with the lack of affect when applied
acutely to SCG cells. The delay is likely to reﬂect the binding and
internalisation of the toxin.
4.2. Direct effect on Kv7 (M) current
PMT also directly stimulates Gaq (Wilson et al., 1997; Baldwin
et al., 2003; Orth et al., 2007), therefore we might have expected
PMT itself to inhibit M-current. As show in Fig. 2, PMT had no direct
effect on the Kv7 (M)-current in terms of amplitude or voltage
dependence. This may suggest that its actions requires the activa-
tion of the G-protein, as often seen with compounds that block
GTPase activity, such as GTP-g-S (Robbins et al., 1993). In this case
the PMT itself should have stimulated PIP2 hydrolysis, reduced
membrane PIP2 and amplitude of the potassium current. The
reason why this inhibition was not seen is likely to be due to the
slow effect of PMT (Lax et al., 2004). The resultant PIP2 hydrolysis
and rise in [Ca]i (as seen in NG108-15 cells at 3e4 h incubation,
Fig. 9A) can stimulate PI4 kinase (Koizumi et al., 2002) thereby
sustaining membrane PIP2 levels (Winks et al., 2005; Zaika et al.,
2006) which maintains the current amplitude. It is also possible
that PMT applied in the absence of agonist(s) cannot activate Gq/
G11 to an extent to deplete PIP2 enough to produce a signiﬁcant
inhibition of Kv(M)-current. It has been demonstrated that to get
even the 18% (non-signiﬁcant) inhibition in M-current observed in
these experiments, PIP2 levels would have to fall by about 50%
(Winks et al., 2005).
4.3. Gq and G11 molecular targets
Relatively recently the molecular targets of PMT have been
identiﬁed (Orth et al., 2009, 2013; Babb et al., 2012). Deamination of
homologous glutamine residues in G-protein alpha subunits of Gi,
Gq, G12 and G13 reduces GTPase activity and leads to increased
activation after receptor stimulation. For G11 it seems the situation
is more complex. Originally it was thought that G11 was not a
molecular target for PMT (Zywietz et al., 2001; Orth et al., 2004,
2007, 2009). More recently however this view has changed to
suggest that G11 is also a target (Kamitani et al., 2011; Babb et al.,
2012; Orth et al., 2013) albeit that PMT activation of G11 is
weaker (Kamitani et al., 2011).
Both Gq and G11 are present in SCGs (Fig. 1) and NG108-15 cells
(Williams and Kelly, 1993). The presence in SCGs of at least two of
the ﬁve PMT sensitive G-proteins has been demonstrated here by
immunocytochemistry and by others using functional antibodies
(Caulﬁeld et al., 1994; Jones et al., 1995) and antisense RNA (Haley
et al., 1998). Consistent with mRNA measurements comparing Gq
and G11 in SCG (Caulﬁeld et al., 1994) and in cerebellar Purkinje
cells (Hartmann et al., 2004) our immunostaining results show
that Gq is more highly expressed than G11. However PMT causedno large alteration in the absolute or relative expression of either
G-protein, indicating that the effect of PMT was not due to
increased levels of G protein subunits. Our results are consistent
with this in that the transduction pathways that were enhanced,
Kv7.2 þ 7.3 inhibition, in SCG neurones and calcium increased in
NG108-15 cells, have been shown to be mediated by Gq and/or G11
G-proteins (Caulﬁeld et al., 1994; Haley et al., 1998), whereas the
pathway that do not involve a PMT sensitive G-protein (Go-
mediated inhibition of calcium current; Delmas et al., 1998) was
unaffected. There does however seem to be an inconsistency in
that the Kv7(M)-current inhibition by angiotensin and bradykinin
was not altered by PMT whereas the increased mobilisation of PIP2
was evident for all three receptors. For bradykinin, the explanation
may be related to the fact that M-current inhibition produced by
bradykinin (unlike that produced by oxotremorine-M) results not
from PIP2 depletion but from the effects of Ca2þ ions released by
the cytosolic product of PIP2 hydrolysis, IP3 (Cruzblanca et al.,
1998; Gamper and Shapiro, 2003). Furthermore the bradykinin
receptors and IP3 receptors responsible for this are organised into
anatomically-discrete signalling ‘microdomains’, as opposed to the
more diffuse location of the mAChRs (Delmas et al., 2002). How-
ever, not all of the bradykinin receptors are conﬁned to these
microdomains (Delmas et al., 2002), and those in the rest of the
cell membrane would be expected to couple avidly to the abun-
dant Gq protein, just like the diffusely-distributed mAChRs. Their
effect may dominate the globally-observed PIP2 hydrolysis as
visualised with the GFP-PLCd-PH construct, and hence become
enhanced by PMT, but this would not contribute to M-current
inhibition since it may not be associated with signiﬁcant PIP2
depletion (see Gamper et al., 2005; Winks et al., 2005) and would
not generate a Ca2þ signal (Delmas et al., 2002). As further evi-
dence for a dissociation between global PIP2 hydrolysis and M-
current inhibition by bradykinin, the concentration of bradykinin
required to induce translocation of GFP-PLCd-PH is substantially
above that which inhibits M-current: the IC50 for the latter is about
1 nM (Jones et al., 1995; see also Fig. 4), whereas concentrations
above this are needed to translocate GFP-PLCd-PH (Winks et al.,
2005, and Fig. 5). In contrast, the concentrationeresponse curves
for the two readouts of mAChR-effects are virtually identical
(Winks et al., 2005). In the recent work elegantly quantifying and
modelling both arms of the Gq signalling pathway (Dickson et al.,
2013; Falkenburger et al., 2013) it is seen that calcium increases are
saturated by the IP3 generated from small amounts of PIP2 hy-
drolysis. This then means that the PMT mediated increase in PIP2
hydrolysis monitor by GFP-PLCd-PH would not substantially in-
crease PIP2 depletion and thereby not enhance M-current inhibi-
tion produced by bradykinin.
We rather assume that the mechanism for M-current inhibition
by angiotensin II is more similar to that for bradykinin rather than
for oxotremorine-M, as judged from the comparable effects of PMT
on the two peptides. Although there is evidence that angiotensin II
may behave more like muscarine than bradykinin (Zhang et al.,
2011), the identity of its cognate G-protein has not been
determined.
4.4. Mutant PMT
We have demonstrated in two cell types that the PMT C1165S
mutant does not signiﬁcantly shift the concentration inhibition
curves for muscarinic receptor inhibition of Kv7 (M)-current in SCG
nor does it enhance the muscarinic receptor evoked calcium rise in
NG108-15 cells (Fig. 7). This may suggest that C1165 plays an
important part in the deamidation of the G-proteins and that
tyrosine phosphorylation is not a necessary step in the activity of
PMT (Ward et al., 1998).
S.M. Surguy et al. / Neuropharmacology 77 (2014) 9e18 174.5. Other G-proteins
We have demonstrated under conditions that favour Go medi-
ated inhibition of voltage-gated calcium current that PMT is inef-
fective. Although it is possible that a proportion of this inhibition
could be mediated by Gi beta/gamma subunits (Delmas et al., 1999)
however the proportion of voltage insensitive inhibition did not
alter signiﬁcantly in the presence of PMT indicating that either
there was minimal Gi mediated inhibition or less likely that PMT
does not activate Gi under these conditions. At present the effects
we have shown can be explained predominantly by activation of Gq
and/or G11. However there are other PMT sensitive G-proteins in
the cells we have used in this study. For example NG108-15 cells
express G12 and G13 (Spicher et al., 1994) as well as Gi2 and Gi3
(Wilk-Blaqszczak et al., 1996) so it would be expected that other
signalling pathways are also being activated.
4.6. Conclusions
Kv7.2 þ 7.3 channels are located in critical parts of neurones in
both peripheral and central nervous systems, namely the nodes of
Ranvier and the axon initial segment (Devaux et al., 2004; Schwarz
et al., 2006; Hu et al., 2007). Functional deﬁcits of these channels
mediated by genetic mutations (BFNS) or blockade by drugs
directly or toxins indirectly can lead to hyperexcitability and ulti-
mately seizures. Increases in intracellular calcium can have multi-
ple effects including increasing neuronal excitability. Therefore,
although not all human isolates of P. multocida are toxigenic, we
would predict that PMT toxicity in the CNS of humans would pre-
sent with hyperexcitability symptoms such as seizures. For PMT to
have a direct effect on the brain, it must cross the blood brain
barrier. At present there is no direct evidence for or against this in
animals or humans. Indeed seizures reported in meningitis may be
mediated by a mechanism other than a toxigenic effect on the
neurones.
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